| WKY |
body weight |
sham surgical control condition (for 224 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
body mass |
male |
266.0 days-280.0 days |
5 |
|
|
562.0 |
g |
22.0 |
49.19 |
body weighing method |
0.0 |
lad occlusion sham |
210 |
days |
|
100273 |
2460 |
| WKY |
heart rate |
sham surgical control condition (for 224 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart pumping trait |
male |
266.0 days-280.0 days |
5 |
|
|
398.0 |
beats/min |
37.0 |
82.73 |
echocardiography |
0.0 |
lad occlusion sham |
210 |
days |
|
100312 |
2460 |
| WKY |
left ventricular end-diastolic blood pressure |
sham surgical control condition (for 224 days) then ketamine (80 mg/kg) then xylazine (10 mg/kg) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricular blood pressure trait |
male |
266.0 days-280.0 days |
5 |
10 min mean |
continuous mean |
5.5 |
mmHg |
2.4 |
5.37 |
vascular transducer tipped catheter |
0.0 |
lad occlusion sham |
210 |
days |
|
100324 |
2460 |
| WKY |
plasma creatinine level |
sham surgical control condition (for 196 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
blood creatinine amount |
male |
238.0 days-252.0 days |
6 |
|
|
0.41 |
mg/dl |
0.03 |
0.07 |
plasma creatinine analysis |
0.0 |
lad occlusion sham |
196 |
days |
|
100363 |
2460 |
| WKY |
artery tunica media width to artery inner diameter ratio |
sham surgical control condition (for 196 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
kidney blood vessel morphology trait |
male |
238.0 days-252.0 days |
11 |
|
|
1.89 |
null |
0.12 |
0.4 |
ex vivo light microscopy with histochemistry and digital image analysis |
0.0 |
lad occlusion sham |
196 |
days |
|
100386 |
2460 |
| WKY |
ejection fraction |
sham surgical control condition (for 224 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
cardiac output trait |
male |
266.0 days-280.0 days |
5 |
|
|
86.8 |
% |
1.5 |
3.35 |
echocardiography |
0.0 |
lad occlusion sham |
210 |
days |
|
100300 |
2460 |
| WKY |
heart left ventricle end-diastolic diameter |
sham surgical control condition (for 224 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricle end-diastolic diameter |
male |
266.0 days-280.0 days |
5 |
|
|
7.9 |
mm |
0.2 |
0.45 |
echocardiography |
0.0 |
lad occlusion sham |
210 |
days |
|
100306 |
2460 |
| WKY |
diastolic blood pressure |
sham surgical control condition (for 224 days) then ketamine (80 mg/kg) then xylazine (10 mg/kg) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
arterial blood pressure trait |
male |
266.0 days-280.0 days |
5 |
10 min mean |
continuous mean |
63.3 |
mmHg |
6.9 |
15.43 |
vascular transducer tipped catheter |
0.0 |
lad occlusion sham |
210 |
days |
|
100318 |
2460 |
| WKY |
maximum rate of positive change in left ventricular blood pressure |
sham surgical control condition (for 224 days) then ketamine (80 mg/kg) then xylazine (10 mg/kg) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricular blood pressure trait |
male |
266.0 days-280.0 days |
5 |
10 min mean |
continuous mean |
4225.0 |
mmHg/s |
525.0 |
1173.94 |
vascular transducer tipped catheter |
0.0 |
lad occlusion sham |
210 |
days |
|
100327 |
2460 |
| WKY |
serum potassium level |
sham surgical control condition (for 224 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
blood potassium amount |
male |
266.0 days-280.0 days |
5 |
|
|
5.3 |
mmol/l |
0.37 |
0.83 |
automated serum potassium test |
0.0 |
lad occlusion sham |
210 |
days |
|
100333 |
2460 |
| WKY |
heart ventricle septal wall thickness |
sham surgical control condition (for 196 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricle wall thickness |
male |
238.0 days-252.0 days |
12 |
|
|
0.14 |
cm |
0.01 |
0.03 |
echocardiography |
0.0 |
lad occlusion sham |
196 |
days |
|
100336 |
2460 |
| WKY |
heart left ventricle fractional shortening |
sham surgical control condition (for 196 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricle end-diastolic diameter |
male |
238.0 days-252.0 days |
12 |
|
|
41.1 |
% |
3.0 |
10.39 |
echocardiography |
0.0 |
lad occlusion sham |
196 |
days |
|
100348 |
2460 |
| WKY |
ejection fraction |
sham surgical control condition (for 196 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
cardiac output trait |
male |
238.0 days-252.0 days |
12 |
|
|
75.8 |
% |
3.9 |
13.51 |
echocardiography |
0.0 |
lad occlusion sham |
196 |
days |
|
100351 |
2460 |
| WKY |
timed urine volume |
sham surgical control condition (for 196 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
urine output |
male |
238.0 days-252.0 days |
7 |
|
|
13.9 |
ml/d |
1.6 |
4.23 |
urine volume measurement method |
0.0 |
lad occlusion sham |
196 |
days |
|
100360 |
2460 |
| WKY |
systolic blood pressure |
sham surgical control condition (for 224 days) then ketamine (80 mg/kg) then xylazine (10 mg/kg) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
arterial blood pressure trait |
male |
266.0 days-280.0 days |
5 |
10 min mean |
continuous mean |
97.8 |
mmHg |
6.3 |
14.09 |
vascular transducer tipped catheter |
0.0 |
lad occlusion sham |
210 |
days |
|
100315 |
2460 |
| WKY |
serum sodium level |
sham surgical control condition (for 224 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
blood sodium amount |
male |
266.0 days-280.0 days |
5 |
|
|
157.7 |
mmol/l |
6.4 |
14.31 |
automated serum sodium test |
0.0 |
lad occlusion sham |
210 |
days |
|
100330 |
2460 |
| WKY |
body weight |
sham surgical control condition |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
body mass |
male |
42.0 days-56.0 days |
12 |
|
|
223.0 |
g |
1.4 |
4.85 |
body weighing method |
0.0 |
lad occlusion |
|
days |
|
100267 |
2460 |
| WKY |
lung wet weight |
sham surgical control condition (for 196 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
lung mass |
male |
238.0 days-252.0 days |
12 |
|
|
1.78 |
g |
0.05 |
0.16 |
post excision weight measurement |
0.0 |
lad occlusion sham |
196 |
days |
|
100297 |
2460 |
| WKY |
timed urine volume |
sham surgical control condition (for 196 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
urine output |
male |
238.0 days-252.0 days |
7 |
|
|
13.9 |
ml/d |
1.6 |
4.23 |
urine volume measurement method |
0.0 |
lad occlusion sham |
196 |
days |
|
100374 |
2460 |
| WKY |
kidney fibrotic lesion area to total kidney area ratio |
sham surgical control condition (for 196 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
kidney integrity trait |
male |
238.0 days-252.0 days |
11 |
|
|
0.91 |
% |
0.03 |
0.1 |
ex vivo light microscopy with histochemistry and digital image analysis |
0.0 |
lad occlusion sham |
196 |
days |
|
100383 |
2460 |
| WKY |
right kidney wet weight |
sham surgical control condition (for 196 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
kidney mass |
male |
238.0 days-252.0 days |
12 |
|
|
1.38 |
g |
0.07 |
0.24 |
post excision weight measurement |
0.0 |
lad occlusion sham |
196 |
days |
|
100371 |
2460 |
| WKY |
body weight |
sham surgical control condition (for 196 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
body mass |
male |
238.0 days-252.0 days |
12 |
|
|
566.0 |
g |
17.0 |
58.89 |
body weighing method |
0.0 |
lad occlusion sham |
196 |
days |
|
100270 |
2460 |
| WKY |
heart weight |
sham surgical control condition (for 196 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart mass |
male |
238.0 days-252.0 days |
12 |
|
|
1.19 |
g |
0.04 |
0.13 |
post excision weight measurement |
0.0 |
lad occlusion sham |
196 |
days |
|
100276 |
2460 |
| WKY |
heart weight |
sham surgical control condition (for 224 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart mass |
male |
266.0 days-280.0 days |
5 |
|
|
1.27 |
g |
0.07 |
0.16 |
post excision weight measurement |
0.0 |
lad occlusion sham |
210 |
days |
|
100279 |
2460 |
| WKY |
heart weight to tibia length ratio |
sham surgical control condition (for 224 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart mass |
male |
266.0 days-280.0 days |
5 |
|
|
0.28 |
g/cm |
0.01 |
0.02 |
post excision weight measurement |
0.0 |
lad occlusion sham |
210 |
days |
|
100282 |
2460 |
| WKY |
heart left ventricle weight |
sham surgical control condition (for 224 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricle mass |
male |
266.0 days-280.0 days |
5 |
|
|
0.84 |
g |
0.02 |
0.05 |
post excision weight measurement |
0.0 |
lad occlusion sham |
210 |
days |
|
100291 |
2460 |
| WKY |
heart left ventricle weight to tibia length ratio |
sham surgical control condition (for 224 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricle mass |
male |
266.0 days-280.0 days |
5 |
|
|
0.19 |
g/cm |
0.01 |
0.01 |
post excision weight measurement |
0.0 |
lad occlusion sham |
210 |
days |
lv/tl |
100294 |
2460 |
| WKY |
left ventricular end-systolic blood pressure |
sham surgical control condition (for 224 days) then ketamine (80 mg/kg) then xylazine (10 mg/kg) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricular blood pressure trait |
male |
266.0 days-280.0 days |
5 |
10 min mean |
continuous mean |
93.0 |
mmHg |
5.8 |
12.97 |
vascular transducer tipped catheter |
0.0 |
lad occlusion sham |
210 |
days |
|
100321 |
2460 |
| WKY |
heart left ventricle end-diastolic diameter |
sham surgical control condition (for 196 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricle end-diastolic diameter |
male |
238.0 days-252.0 days |
12 |
|
|
8.3 |
mm |
0.2 |
0.69 |
echocardiography |
0.0 |
lad occlusion sham |
196 |
days |
|
100339 |
2460 |
| WKY |
E/A wave ratio |
sham surgical control condition (for 196 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
blood flow trait |
male |
238.0 days-252.0 days |
12 |
|
|
1.39 |
null |
0.15 |
0.52 |
echocardiography |
0.0 |
lad occlusion sham |
196 |
days |
e/a wave |
100354 |
2460 |
| WKY |
right kidney wet weight |
sham surgical control condition (for 196 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
kidney mass |
male |
238.0 days-252.0 days |
12 |
|
|
1.38 |
g |
0.07 |
0.24 |
post excision weight measurement |
0.0 |
lad occlusion sham |
196 |
days |
|
100357 |
2460 |
| WKY |
plasma creatinine level |
sham surgical control condition (for 196 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
blood creatinine amount |
male |
238.0 days-252.0 days |
6 |
|
|
0.41 |
mg/dl |
0.03 |
0.07 |
plasma creatinine analysis |
0.0 |
lad occlusion sham |
196 |
days |
|
100377 |
2460 |
| WKY |
tibia length |
sham surgical control condition (for 224 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
tibia length |
male |
266.0 days-280.0 days |
5 |
|
|
4.3 |
cm |
0.12 |
0.27 |
post excision length measurement |
0.0 |
lad occlusion sham |
210 |
days |
|
100285 |
2460 |
| WKY |
heart left ventricle weight |
sham surgical control condition (for 196 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricle mass |
male |
238.0 days-252.0 days |
12 |
|
|
0.85 |
g |
0.03 |
0.09 |
post excision weight measurement |
0.0 |
lad occlusion sham |
196 |
days |
|
100288 |
2460 |
| WKY |
heart left ventricle fractional shortening |
sham surgical control condition (for 224 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricle end-diastolic diameter |
male |
266.0 days-280.0 days |
5 |
|
|
51.5 |
% |
1.7 |
3.8 |
echocardiography |
0.0 |
lad occlusion sham |
210 |
days |
|
100303 |
2460 |
| WKY |
heart left ventricle end-systolic diameter |
sham surgical control condition (for 224 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricle end-systolic diameter |
male |
266.0 days-280.0 days |
5 |
|
|
3.8 |
mm |
0.3 |
0.67 |
echocardiography |
0.0 |
lad occlusion sham |
210 |
days |
|
100309 |
2460 |
| WKY |
heart left ventricle end-systolic diameter |
sham surgical control condition (for 196 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricle end-systolic diameter |
male |
238.0 days-252.0 days |
12 |
|
|
4.9 |
mm |
0.3 |
1.04 |
echocardiography |
0.0 |
lad occlusion sham |
196 |
days |
|
100342 |
2460 |
| WKY |
heart posterior wall thickness |
sham surgical control condition (for 196 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricle posterior wall thickness |
male |
238.0 days-252.0 days |
12 |
|
|
0.17 |
cm |
0.01 |
0.03 |
echocardiography |
0.0 |
lad occlusion sham |
196 |
days |
|
100345 |
2460 |